VeriMomsalicyloyl oligopeptide-143 est-il sûr pendant la grossesse ?
No harmonised CLP classification, no CIR or SCCS safety assessment specifically for salicyloyl oligopeptide-143, and no peer‑reviewed reproductive/toxicity studies identified (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, ECHA dossiers, CosIng, PubChem, EWG). The only plausible theoretical concern is that the salicyloyl group could release salicylic acid, but there is no direct evidence that this ingredient causes reproductive toxicity. Therefore hazard = 0 (no evidence), mechanism = 1 (theoretical only: potential release of salicylate), exposure = 1 (topical cosmetic use — low but potentially measurable absorption).
Related ingredients
Frequently asked questions
- salicyloyl oligopeptide-143 est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no CIR or SCCS safety assessment specifically for salicyloyl oligopeptide-143, and no peer‑reviewed reproductive/toxicity studies identified (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, ECHA dossiers, CosIng, PubChem, EWG). The only plausible theoretical concern is that the salicyloyl group could release salicylic acid, but there is no direct evidence that this ingredient causes reproductive toxicity. Therefore hazard = 0 (no evidence), mechanism = 1 (theoretical only: potential release of salicylate), exposure = 1 (topical cosmetic use — low but potentially measurable absorption).
- salicyloyl oligopeptide-143 est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy. No specific data showing transfer into milk or effects on lactation; theoretical concern only via possible salicylate release. For normal cosmetic topical use exposure is expected to be low.
- salicyloyl oligopeptide-143 est-il sûr pour la peau de bébé ?
- No infant-specific toxicology or clinical data located. Hazard remains 0 (no evidence). Mechanistic concern is theoretical only (possible salicyloyl → salicylic acid). Exposure score increased by +1 for infants due to immature barrier and higher surface‑area‑to‑weight, so e = 2 (moderate relative exposure).
- Comment VeriMom évalue-t-il salicyloyl oligopeptide-143 ?
- VeriMom évalue salicyloyl oligopeptide-143 à 87/100 (risque faible) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à salicyloyl oligopeptide-143 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à salicyloyl oligopeptide-143 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.